ERBB2 and adenocarcinoma: EBVaGCs with intestinal histology were frequently accompanied by genetic alterations, which were known to frequently occur in conventional intestinal-type adenocarcinoma, including KRAS, FBXW7, MUC6, ERBB2, CTNNB1, and ERBB2 amplification mutations16,17.